摘要
目的:总结我院2010年药品不良反应(ADR)监测情况,为安全用药提供参考。方法:对2010年经审核合格评价上报的853例ADR报告中涉及的药品种类进行分类、统计排名,重点分析新的、严重的ADR的发生情况及相关因素。结果:抗菌药物排名前3位的是阿奇霉素、左氧氟沙星、依诺沙星;中药制剂排名前3位是鹿瓜多肽注射液、舒血宁注射液、尿石通丸;营养药及生化制剂排名前3位的是复方氨基酸注射液(18F)、三磷酸腺苷二钠氯化镁注射液、水解蛋白。其中新的ADR125例,严重ADR27例。结论:应重视ADR的监测和上报工作,把安全用药放在合理用药第一位,减少新的、严重的ADR发生。
Objective： To review the situation of adverse drug reaction （ADR） monitoring in our hospital in 2010 so as to provide a reference for clinical safe medication. Methods： The categories of the drugs involved in 853 ADR cases were classified, counted and ranked. Emphasis was placed on the occurrence and relevant factors of new and severe ADRs. Results： The top three antimicrobial drugs were azithromycin, levofloxacin and enoxacin. The top three Chinese herbal preparations were cervus and cucumis polypeptide injection, ginkgo biloba extract injection and virustatic pills. The top three nutrition medicines and biochemical preparations were compound amino acid injection （18F）, adenosine disodium triphosphate and magnesium chloride for injection and proteine hydrolysate. Among them, there were 125 new ADR cases and 27 severe ADR cases in total. Conclusion： ADR monitoring and reporting should be strengthened and safe medication should be put in the first place in rational drug use so as to reduce the incidence of new and serious ADRs.
出处
《中国执业药师》
CAS
2012年第10期12-16,共5页
China Licensed Pharmacist
关键词
药品不良反应
监测
报告
Adverse Drug Reactions
Monitoring
Report
